dr. o’reilly on the utility of parp inhibitors in pancreatic cancer
Published 4 years ago • 126 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
1:18
dr. o’reilly on ongoing trials with parp inhibitors in pancreatic cancer
-
1:19
dr. o’reilly on the potential role of veliparib in pancreatic cancer
-
1:32
dr. o’reilly on the role of germline testing in pancreatic cancer
-
1:51
dr. o’reilly on investigational treatment approaches in pancreatic cancer
-
2:14
dr. o’reilly on agents in development in advanced pancreatic cancer
-
5:02
parp inhibitors in pancreatic cancer
-
0:59
dr. simeone on impact of parp inhibitors on pancreatic cancer
-
1:07
quality of life data for parp inhibitor shows promise for pancreatic cancer treatment
-
0:47
dr. richards on parp inhibition in pancreatic cancer
-
1:20
dr. o'reilly discusses biomarker research in pancreatic cancer
-
1:58
dr. o'reilly on areas of research in pancreatic cancer
-
2:24
dr. o'reilly on tarextumab combinations for metastatic pancreatic cancer
-
0:58
dr. o’malley on the optimal use of parp inhibitors in advanced ovarian cancer
-
1:53
dr. o'reilly on resistance to immunotherapy in pancreatic cancer
-
12:23
emerging therapies for pancreatic cancer
-
2:56
eileen o'reilly, md, on the phase 2 study comparing chemo with or without veliparib in pancreas
-
1:13
dr. o'reilly discusses new developments in pancreatic cancer care
-
1:09
dr. o'reilly on immunotherapy in pancreatic cancer
-
3:45
parp inhibitors gbrca1/2-mutated pancreatic cancer